Gold prices steady, holding sharp gains in wake of soft U.S. jobs data
Investing.com - Ossur reported on Friday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Ossur announced earnings per share of $0.03 on revenue of $181M. Analysts polled by Investing.com EPS of $0.0308 on revenue of $192.47M.
Ossur 's are down 31% and is trading at $30.45 , still down 34.59% from its 52 week high of $46.55 set on Wednesday, September 15, 2021.
Ossur follows other major Healthcare sector earnings this month
Ossur's report follows an earnings beat by Coloplast on Wednesday, August 17, 2022, who reported EPS of $6.14 on revenue of $5.85B, EPS of $5.92 on revenue of $5.74B.
Demant had beat expectations on Monday, August 15, 2022 with second quarter EPS of $5.04 on revenue of $4.89B, for EPS of $4.91 on revenue of $5.02B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar